While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...
Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...
In a recent study published in Science Advances, researchers generated a recombinant influenza virus expressing micro ribonucleic acid (miRNAs) expressed in cardiomyocytes to infect mice, which served ...
TOKYO & PALO ALTO, Calif.--(BUSINESS WIRE)--Heartseed Inc. ("Heartseed"), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure and I Peace Inc. ("I Peace"), a ...
New evidence reveals adult human hearts can regrow muscle cells after myocardial infarction, opening new possibilities for ...
Novel technology returns cardiomyocytes to a stem cell-like state to promote their proliferation and regeneration in an in vitro study. Researchers at the University of Houston (TX, USA) have ...
The induction of the cell cycle in cardiomyocytes involves the activation of specific genes that are responsible for regulating cell division and growth. Our laboratory has discovered several ...
“For decades, researchers have been trying to find the specialized cells that make new muscle cells in the adult heart, and we think that we have found that cell,” Hesham Sadek, the senior author of ...
Novel tissue-embedded nanosensor shows that co-culturing stem-cell-derived cardiomyocytes with endothelial cells leads to more functionally mature cardiomyocytes. Heart muscle cells, called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results